Gone to pastures new where the grass is greener and the sky bluer. https://xitter.cf/t.co/ZrSUWPQKFd
Sutton, London
Joined April 2011
- Tweets7.2K
- Following0
- Followers2.8K
- Likes10.2K
A high-powered event that wasn't overwhelming and had plenty of opportunity for productive conversation 😃 . I really enjoyed it.
Michael Hubank retweeted
A year ago in Davos I predicted a "Dreadnought moment" for AI.
youtu.be/7_YULkhecm4?si=hdS2…
Is DeepSeek the Dreadnought moment?
No, it's just a small change in the recipe, but it's indicative that there's plenty more room for innovation. DeepSeek won't be the last DeepSeek ...
Michael Hubank retweeted
We are delighted that Michael Hubank (@Generoom, Head of Clinical Genomics (Research) @royalmarsdenNHS) is joining us next week at #FOG2025! Don’t miss hearing from him, register now: hubs.la/Q032-l9j0
#FOG2025
Michael Hubank retweeted
#Cancer remains a leading cause of death in children, with the emergence of treatment resistance being the main problem. We need serially matched data on evolving tumours to understand what causes resistance! Thanks @CR_UK for funding studies like this. aacrjournals.org/cancerdisco…
Now online in @CD_AACR: Stratified Medicine Pediatrics: Cell-Free DNA & Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution & Epigenetic States - by @SallyLGeorge, Claire Lynn, @RStankunaite, @AndreaSottoriva, Louis Chesler, et al. doi.org/10.1158/2159-8290.CD…
Michael Hubank retweeted
🎄 Merry Christmas! 🎄
🔔 As Advent ends, the 12 Days of Christmas🎄begin!
Join me for a deeper dive into the initiatives shown in this map - from Data Science Africa to @ai.cam.ac.uk - as we explore practical responses to AI challenges.
the-atomic-human.ai/reflecti…
Highly recommend!
#FOG2025’s precision medicine roundtable will demonstrate how precision medicine can revolutionize global healthcare through optimized technologies, implementation and adoption to elevate patient care. More info: hubs.la/Q02YcD9h0
Michael Hubank retweeted
Nine weeks to go until The Festival of Genomics and Biodata returns to London! There’s no better place to learn, network and be inspired, so come along and join 7,000+ attendees at the UK’s biggest life sciences event. Register now: hubs.la/Q02WY63d0 #FOG2025
Michael Hubank retweeted
ctDNA status & dynamics predict recurrence in resected extrahepatic cholangiocarcinoma
@JHepatology
doi.org/10.1016/j.jhep.2024.…
🔎STAMP
👉ctDNA+ after resection is predictive (as expected)
👉adj. CTx may convert some pts to ctDNA- w/ better outome (reassuring..)
@myESMO @EASLnews @ILCAnews #livertwitter @curecc
Michael Hubank retweeted
Got a PhD in bioinformatics or quantiative/CS degree? Want to work with AI on real world health care data, using some of the biggest datasets in the world? Want to live in Cambridge UK and work in European EMBL? This job in my research group is for you! embl.org/jobs/position/EBI02…
Brilliant. @mattloose @SjsmithStuart and Simon Paine are really paving the way for rapid Nanopore Dx in England. Huge creds! And thankyou for supporting us as we aim to establish this @NorthThamesGMS 😃
Congrats to @SjsmithStuart and Dr Simon Paine for winning the #NIHAwards Innovation award for work on bringing @nanopore sequencing into the clinic for rapid brain tumour diagnosis.
Michael Hubank retweeted
Interested in how low-cost, high accuracy sequencing can be used to assess #ctDNA? The come along to #FOG2025 to hear from @Landau_Lab (Assistant Professor and Associate Core Member, @NYGenome)! You can register here: hubs.la/Q02Y8p9x0
Michael Hubank retweeted
Oxford Nanopore announces senior leadership team changes | Oxford Nanopore Technologies
nanoporetech.com/news/oxford…
Michael Hubank retweeted
The Liquid Biopsy ONLINE series ends on Tuesday and we have three great speakers to close the series including @AlastairGreyst2 who will be speaking about the lessons learned from the national lung cancer pilot.
Register here: hubs.la/Q02XDwd40
#liquidbiopsy
The dangers of screening when you dont know what to do with the result.
hello @wesstreeting : honestly, the best thing to do is ensure that the UK National Screening Committee are doing the best job in critically appraising up to date evidence and making fair recommendations;